Search Results - "Brinkmann, Ulrich"
-
1
Engineering therapeutic bispecific antibodies using CrossMab technology
Published in Methods (San Diego, Calif.) (01-02-2019)“…[Display omitted] •CrossMab technology enforce correct light chain in the Fab region of the bispecific antibody.•CrossMab technology is a versatile approach…”
Get full text
Journal Article -
2
Format and geometries matter: Structure-based design defines the functionality of bispecific antibodies
Published in Computational and structural biotechnology journal (01-01-2020)“…Multispecific antibodies can be generated in different formats. More than two decades of R&D in the field of bispecific antibody engineering revealed that the…”
Get full text
Journal Article -
3
Quantitative fluorescence imaging determines the absolute number of locked nucleic acid oligonucleotides needed for suppression of target gene expression
Published in Nucleic acids research (25-01-2019)“…Abstract Locked nucleic acid based antisense oligonucleotides (LNA-ASOs) can reach their intracellular RNA targets without delivery modules. Functional…”
Get full text
Journal Article -
4
DPH1 and DPH2 variants that confer susceptibility to diphthamide deficiency syndrome in human cells and yeast models
Published in Disease models & mechanisms (01-09-2023)“…ABSTRACT The autosomal-recessive diphthamide deficiency syndrome presents as intellectual disability with developmental abnormalities, seizures, craniofacial…”
Get full text
Journal Article -
5
Format chain exchange (FORCE) for high-throughput generation of bispecific antibodies in combinatorial binder-format matrices
Published in Nature communications (02-10-2020)“…Generation of bispecific antibodies (bsAbs) requires a combination of compatible binders in formats that support desired functionalities. Here, we report that…”
Get full text
Journal Article -
6
Generation of binder-format-payload conjugate-matrices by antibody chain-exchange
Published in Nature communications (31-10-2024)“…The generation of antibody-drug conjugates with optimal functionality depends on many parameters. These include binder epitope, antibody format, linker…”
Get full text
Journal Article -
7
Translational fidelity and growth of Arabidopsis require stress-sensitive diphthamide biosynthesis
Published in Nature communications (11-07-2022)“…Diphthamide, a post-translationally modified histidine residue of eukaryotic TRANSLATION ELONGATION FACTOR2 (eEF2), is the human host cell-sensitizing target…”
Get full text
Journal Article -
8
Importance of diphthamide modified EF2 for translational accuracy and competitive cell growth in yeast
Published in PloS one (18-10-2018)“…In eukaryotes, the modification of an invariant histidine (His-699 in yeast) residue in translation elongation factor 2 (EF2) with diphthamide involves a…”
Get full text
Journal Article -
9
Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies
Published in mAbs (01-11-2012)“…The development of bispecific antibodies has attracted substantial interest, and many different formats have been described. Those specifically containing an…”
Get full text
Journal Article -
10
DPH1 Gene Mutations Identify a Candidate SAM Pocket in Radical Enzyme Dph1•Dph2 for Diphthamide Synthesis on EF2
Published in Biomolecules (Basel, Switzerland) (16-11-2023)“…In eukaryotes, the Dph1•Dph2 dimer is a non-canonical radical SAM enzyme. Using iron-sulfur (FeS) clusters, it cleaves the cosubstrate S-adenosyl-methionine…”
Get full text
Journal Article -
11
Functional Integrity of Radical SAM Enzyme Dph1•Dph2 Requires Non-Canonical Cofactor Motifs with Tandem Cysteines
Published in Biomolecules (Basel, Switzerland) (01-04-2024)“…The Dph1•Dph2 heterodimer from yeast is a radical SAM (RS) enzyme that generates the 3-amino-3-carboxy-propyl (ACP) precursor for diphthamide, a clinically…”
Get full text
Journal Article -
12
Targeted chain-exchange-mediated reconstitution of a split type-I cytokine for conditional immunotherapy
Published in mAbs (31-12-2023)“…Antibody-cytokine fusions targeted against tumor-associated antigens (TAAs) are promising cancer immunotherapy agents, with many such molecules currently…”
Get full text
Journal Article -
13
Zirconium-89 Labeled Antibodies : A New Tool for Molecular Imaging in Cancer Patients
Published in BioMed research international (01-01-2014)“…Antibody based positron emission tomography (immuno-PET) imaging is of increasing importance to visualize and characterize tumor lesions. Additionally, it can…”
Get full text
Journal Article -
14
Diphthamide affects selenoprotein expression: Diphthamide deficiency reduces selenocysteine incorporation, decreases selenite sensitivity and pre-disposes to oxidative stress
Published in Redox biology (01-01-2019)“…The diphthamide modification of translation elongation factor 2 is highly conserved in eukaryotes and archaebacteria. Nevertheless, cells lacking diphthamide…”
Get full text
Journal Article -
15
Loss of diphthamide pre-activates NF-κB and death receptor pathways and renders MCF7 cells hypersensitive to tumor necrosis factor
Published in Proceedings of the National Academy of Sciences - PNAS (25-08-2015)“…The diphthamide on human eukaryotic translation elongation factor 2 (eEF2) is the target of ADP ribosylating diphtheria toxin (DT) andPseudomonasexotoxin A…”
Get full text
Journal Article -
16
A Novel Glycoengineered Bispecific Antibody Format for Targeted Inhibition of Epidermal Growth Factor Receptor (EGFR) and Insulin-like Growth Factor Receptor Type I (IGF-1R) Demonstrating Unique Molecular Properties
Published in The Journal of biological chemistry (04-07-2014)“…In the present study, we have developed a novel one-arm single chain Fab heterodimeric bispecific IgG (OAscFab-IgG) antibody format targeting the insulin-like…”
Get full text
Journal Article -
17
Yeast gene KTI13 (alias DPH8) operates in the initiation step of diphthamide synthesis on elongation factor 2
Published in Microbial cell (04-09-2023)“…In yeast, Elongator-dependent tRNA modifications are regulated by the Kti11•Kti13 dimer and hijacked for cell killing by zymocin, a tRNase ribotoxin. Kti11…”
Get full text
Journal Article -
18
A novel angiopoietin-2 selective fully human antibody with potent anti-tumoral and anti-angiogenic efficacy and superior side effect profile compared to Pan-Angiopoietin-1/-2 inhibitors
Published in PloS one (06-02-2013)“…There is increasing experimental evidence for an important role of Angiopoietin-2 (Ang-2) in tumor angiogenesis and progression. In addition, Ang-2 is…”
Get full text
Journal Article -
19
Characterization of a re-engineered, mesothelin-targeted Pseudomonas exotoxin fusion protein for lung cancer therapy
Published in Molecular oncology (01-10-2016)“…Mesothelin overexpression in lung adenocarcinomas correlates with the presence of activating KRAS mutations and poor prognosis. Hence SS1P, a…”
Get full text
Journal Article -
20
Bispecific digoxigenin-binding antibodies for targeted payload delivery
Published in Proceedings of the National Academy of Sciences - PNAS (17-05-2011)“…Bispecific antibodies that bind cell-surface targets as well as digoxigenin (Dig) were generated for targeted payload delivery. Targeting moieties are IgGs…”
Get full text
Journal Article